PharmInvent´s Global PV Network Covers 5 Continents
Oct 2, 2017
PharmInvent, a specialized provider of pharmacovigilance, and regulatory science consulting and auditing services, is pleased to announce a continuous expansion of its Global Pharmacovigilance Network.
Today, we help our American, European, and Japanese clients meet their regulatory obligations on 5 continents. In cooperation with our sister company Primevigilance we run a reliable global pharmacovigilance network of experienced partners in 60 countries.
"PharmInvent´s Global Pharmacovigilance Network is composed of reliable partners who are qualified QPPVs with in-depth knowledge of the local pharmacovigilance regulatory requirements in their respective markets. Thanks to our very close cooperation with Primevigilance, our Global PV Network is one of the largest local QPPV networks offered by service providers worldwide," says Adam Scheuer, Business Development Director.
Although the pharmacovigilance requirements and regulations in various countries are currently at a different phase in their development compared to the EU GVP for example, there are regulatory requirements which must be fulfilled, and PharmInvent is happy to share its in-depth local knowledge and become a reliable partner to pharmaceutical and biotech companies on their way to drug safety success.